OverviewSuggest Edit
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. The company develops DNA sequencing technology and focuses on accelerating genomic discovery. Its integrated solutions include instruments, consumables, and software for analyzing biological systems.
| Type | Public | |
| Founded | 2012 | |
| HQ | Pleasanton, CA, US | Map |
| Website | 10xgenomics.com | |
| Employee Ratings | More | |
| Overall Culture | C+ | More |
Recent NewsAll News
- 10x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell Analysis on Chromium
- Global Genomics Market Report (2021 to 2030) - Featuring 10x Genomics, Qiagen and Denovo Sciences Among Others
- Outlook on the Genomic Cancer Panel and Profiling Global Market - Featuring 10x Genomics, Abbott Diagnostics and AccuraGen Among Others
- 10x Genomics Adds Global Clinical Research Organizations to Expanded Certified Service Provider Network
Key People/Management at 10X Genomics
Serge Saxonov
Chief Executive Officer, Co-Founder
Kim Popovits
Director
Shehnaaz Suliman
Director
Brad Crutchfield
Chief Commercial Officer
Sridhar Kosaraju
Director
Justin McAnear
Chief Financial Officer
10X Genomics Office Locations
10X Genomics has offices in Pleasanton, San Francisco, Shanghai, Leiden and in 1 other location
Pleasanton, CA, US (HQ)
6230 Stoneridge Mall Rd
San Francisco, CA, US
Three Embarcadero Center, San Francisco
Shanghai, CN
1018 Changning Rd, Zhong Shan Gong Yuan, Changning Qu
Leiden, NL
Schipholweg 103
Singapore, SG
20 Science Park Rd, 02 32a 33
10X Genomics Financials and Metrics
10X Genomics Revenue
10X Genomics's revenue was reported to be $298.85 m in FY, 2020 which is a 21.5% increase from the previous period.
| USD | |
|---|---|
Revenue (Q3, 2021) | 125.3m |
Gross profit (Q3, 2021) | 100.8m |
Gross profit margin (Q3, 2021), % | 80.4% |
Net income (Q3, 2021) | (17.2m) |
EBIT (Q3, 2021) | (15.9m) |
Market capitalization (12-May-2022) | 4.6b |
Closing stock price (12-May-2022) | 40.9 |
Cash (30-Sept-2021) | 600.4m |
EV | 4.0b |
10X Genomics's current market capitalization is $4.6 b.
Annual
Quarterly
| USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 53.6m | 55.8m | 61.2m | 71.9m | 42.9m | 71.8m | 105.8m | 115.8m | 125.3m |
Cost of goods sold | 14.0m | 15.0m | 15.5m | 15.1m | 10.1m | 14.4m | 17.1m | 4.9m | 24.5m |
Gross profit | 39.6m | 40.8m | 45.7m | 56.8m | 32.9m | 57.4m | 88.8m | 110.9m | 100.8m |
Gross profit Margin, % | 74% | 73% | 75% | 79% | 77% | 80% | 84% | 96% | 80% |
Annual
Annual
Quarterly
| USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.6m) | (14.5m) | (24.1m) | (21.1m) | (61.3m) | (127.2m) | (11.6m) | (22.6m) | (39.8m) |
Depreciation and Amortization | 1.0m | 2.2m | 4.2m | 3.2m | 6.5m | 10.1m | 4.8m | 9.6m | 15.3m |
Inventories | (2.6m) | (3.8m) | (4.7m) | (4.1m) | (6.5m) | (9.8m) | (8.6m) | (14.2m) | (21.3m) |
Accounts Payable | (1.3m) | (986.0k) | 2.7m | (653.0k) | (2.8m) | (3.3m) | 10.9m | 9.7m | 12.2m |
| USD | FY, 2018 |
|---|---|
Debt/Equity | -0.1 x |
Debt/Assets | 0.2 x |
Financial Leverage | -0.6 x |
P/E Ratio | (1.4) |
10X Genomics Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Tetramer Shop | February 25, 2021 | |
| ReadCoor | October 05, 2020 | $350 m |
| CARTANA | September 16, 2020 | $41.2 m |
| Spatial Transcriptomics | December 10, 2018 | |
| EPINOMICS | August 28, 2018 |
10X Genomics Revenue Breakdown
10X Genomics revenue breakdown by business segment: 13.4% from Instruments, 84.6% from Consumables and 2.0% from Other
10X Genomics revenue breakdown by geographic segment: 53.3% from North America, 14.0% from China, 24.5% from Europe, the Middle East and Africa and 8.2% from Asia Pacific
10X Genomics Cybersecurity Score
10X Genomics Environment, Social & Governance (ESG) Ratings
10X Genomics Online and Social Media Presence
23.85k Twitter followers
10X Genomics has 23.85k Twitter Followers. The number of followers has increased 1% month over month and increased 3.3% quarter over quarter
10X Genomics's Trends
Twitter Engagement Stats for @10xgenomics
8k
Tweets
775
Following
23.8k
Followers
42
Tweets last 30 days
7.1
Avg. likes per Tweet
95.2%
Tweets with engagement
10X Genomics Company Culture
Overall Culture
C+
69/100
CEO Rating
C-
65/100
Compensation
B
73/100
10X Genomics News and Updates
April 14, 2022
10x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell Analysis on Chromium
Fixed RNA Profiling Kit stabilizes human samples at collection; Nuclei Isolation Kit simplifies frozen sample analysis PLEASANTON, Calif., April 14, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today...
February 21, 2022
Global Genomics Market Report (2021 to 2030) - Featuring 10x Genomics, Qiagen and Denovo Sciences Among Others
Dublin, Feb. 21, 2022 (GLOBE NEWSWIRE) -- The "Genomics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the…
January 28, 2022
Outlook on the Genomic Cancer Panel and Profiling Global Market - Featuring 10x Genomics, Abbott Diagnostics and AccuraGen Among Others
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential Market Size, Forecasting/Analysis, and Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offerin…
January 21, 2022
10x Genomics Adds Global Clinical Research Organizations to Expanded Certified Service Provider Network
PLEASANTON, Calif., Jan. 21, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the expansion of its 10x Certified Service Provider (CSP) Network to include three leading clinical research...
October 25, 2021
10x Genomics Celebrates Opening of Singapore Manufacturing and Commercial Hub
SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today marked a major Asia Pacific (APAC) expansion with the grand opening celebration of its Singapore manufacturing facility and commercial...
September 14, 2021
Genomics Market Witnesses Emergence of 10X Genomics Inc. & Abcam Plc as Key Market Contributors|17000+ Technavio Reports
NEW YORK, Sept. 14, 2021 /PRNewswire/ -- The genomics market is set to grow by $ 14.51 bn, progressing at a CAGR of over 10.36% during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market...
10X Genomics Blogs
December 02, 2019
10 Things to Know About the Chromium Single Cell ATAC Solution
The Scientist recently announced that the Chromium Single Cell ATAC Solution from 10x Genomics is among the Top 10 Innovations of 2019!
In honor of this award, we’d like to share 10, well 9, additional things that we want you to know about ATAC, including some of the discoveries that 10x custo…
November 26, 2019
Uncovering the Role of Hand2 in Congenital Heart Defects
Researchers at the Gladstone Institute of Cardiovascular Diseases recently used single cell RNA sequencing to characterize heart development in mice. They discovered a surprising role for the transcription factor Hand2 in a common phenotype of congenital heart defect. Guest author Jamie Schwendinge…
November 21, 2019
The Tadpole, the Mouse, and the Worm: Studying Development in Model Organisms
How do single cell solutions apply to the study of developmental biology in model organisms? Here we review three publications that demonstrate the power of transcriptional profiling in single cells to uncover the hidden processes of development, including regeneration, cell type specification, and…
November 18, 2019
Automate Your Single Cell Workflow
Register for this 10x-pert webinar, hosted by GEN, on December 3, 2019, to learn about Chromium Connect, the new automated solution from 10x Genomics that combines single cell partitioning, barcoding, and library prep in one optimized instrument.
November 14, 2019
Single Cell Gene Expression Aiding Diabetes Research
November is National Diabetes Month, so we are highlighting some important diabetes research published this year and how 10x Genomics technology played a part in these discoveries.
November 11, 2019
Antibody Discovery and B Cell Profiling Using Single Cell Immune Sequencing
Researchers from Vanderbilt University recently used single cell immune sequencing to identify a new panel of broadly neutralizing antibodies against HIV. Members of the research team, including graduate student Ian Setliff from the lab of Dr. Ivelin Georgiev, will discuss their discoveries in a 10…
10X Genomics Frequently Asked Questions
When was 10X Genomics founded?
10X Genomics was founded in 2012.
Who are 10X Genomics key executives?
10X Genomics's key executives are Serge Saxonov, Kim Popovits and Shehnaaz Suliman.
How many employees does 10X Genomics have?
10X Genomics has 1,148 employees.
What is 10X Genomics revenue?
Latest 10X Genomics annual revenue is $298.8 m.
What is 10X Genomics revenue per employee?
Latest 10X Genomics revenue per employee is $260.3 k.
Who are 10X Genomics competitors?
Competitors of 10X Genomics include Oxford Nanopore Technologies, AbCellera Biologics and Benchling.
Where is 10X Genomics headquarters?
10X Genomics headquarters is located at 6230 Stoneridge Mall Rd, Pleasanton.
Where are 10X Genomics offices?
10X Genomics has offices in Pleasanton, San Francisco, Shanghai, Leiden and in 1 other location.
How many offices does 10X Genomics have?
10X Genomics has 5 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies